Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Cell Marque – Epithelial Membrane Antigen (EMA)

Testing you can trust

Recent independent assessment data has highlighted significant differences in the performance of EMA antibodies currently available on the market. According to a recent NordiQC evaluation, some commonly used EMA clones failed to achieve satisfactory staining performance, prompting recommendations for laboratories to consider more robust alternatives.

Why Consider Cell Marque EMA (clone E29)?

  • Independently assessed by NordiQC
  • Achieved Optimal or Good assessment scores
  • Available in both concentrated and prediluted formats
  • Consistent and reliable staining performance
  • Ideal for laboratories seeking confidence in diagnostic results

The NordiQC assessment specifically reported that a widely used competitor EMA clone did not produce sufficient results and recommended that laboratories consider changing to a more robust antibody. In contrast, Cell Marque’s EMA clone E29 achieved optimal or good performance ratings, demonstrating dependable staining quality across tested protocols.

Cell Marque EMA (E29)

Epithelial Membrane Antigen (EMA) is a well-established marker used in the evaluation of a wide range of epithelial neoplasms. Selecting a high-performing antibody clone is critical to ensuring reliable staining quality and diagnostic confidence.

Read the NordiQC Assessment Report

Learn More

If you would like to evaluate Cell Marque EMA Clone E29 in your laboratory, contact us for further information, pricing, or validation support.

Contact us for an evaluation

Learn More

Request a Quote

Request Quote

Recent Posts

Axlab – AS-410M Auto Slide Preparation System

Automated high-quality, consistent sectioning ideal for digital pathology. The fully automatic sectioning device is capable of cutting up to 96 paraffin blocks as well as…

Read full article

Axlab – AT-192M FFPE Tissue Block Automatic Facing Device

The AT-192M ensures efficient, safe, and accurate tissue block trimming, streamlining workflows and enhancing diagnostic precision. It empowers clinicians to achieve better patient outcomes while…

Read full article

Press Release: Abacus dx Announces Partnership with Axlab

We are pleased to announce an exciting new partnership between Abacus dx and Axlab, bringing advanced automation solutions for histopathology laboratories to the Australian market….

Read full article